Please login to the form below

Not currently logged in
Email:
Password:

Chiltern International lines up Dr Jim Esinhart as next CEO

He will replace Glenn Kerkhof from November 1, 2012

Chiltern International has selected Dr Jim Esinhart to be its next CEO with effect from November 1, 2012.

He will replace Glenn Kerkhof, who is stepping down as CEO of the London-based contract research organisation (CRO) after six years in the post.

Kerkhof will relocate to his native Australia to lead Chiltern's owner Czura Thornton in Asia Pacific, but will join Chiltern's board of directors.

Chiltern's new CEO Dr Esinhart has been with the company for six years and is currently senior executive vice president of global scientific services.

Kerkhof said: “I am delighted to have played my part in the development of Chiltern as a leading mid-tier CRO. Chiltern now employs more than 1,400 people in 34 countries, is financially very strong and is poised for substantial growth.

“I am also delighted to see the CEO position transition to a valued and trusted colleague in Jim Esinhart, who I know will bring a tremendous amount to the role. And I very much look forward to contributing to Chiltern's future as a member of the Board based in the Asia Pacific region.”

9th October 2012

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics